PI-88 excellent CL.II results. Sudden buy back agreement from pipeline at very interesting terms. (Read this very carefully). They know what they have!!!! "The feedback from the FDA meeting in April 2006 has laid the foundation for Progen to take PI-88 through to a Phase III clinical development program three years faster than anticipated." (excerp from Progen web site) I will continue to buy at regulated pace. If clinical III results as good as Clinical II, I expect trial to be cut short and approval given early.....one can only hope!!!!!!!!

Alliance with King Pharm to distribute Remoxy. Abuse resist. Opioids are the answer MD's are waiting for. With oxycontin resulting in very high incident of abuse and MD's being sued or going to jail over this drug in years past, they will flock to any alternative that proves both effective as well as abuse resistant. Also oxytrex showing lower physical dependencies then other opioids. Nice thing is PTIE owns Oxytrex exclusively. Both due for FDA review mid 2007 I believe.

Reviimmune, Uktra-high intensity, short course fromulation of an already APPROVED drug (cyclophosphosphamide0 to "reboot" immune systems in patients with autoimmune disorders. Preliminary data shows very promising results in multitude of auto-immune disorders. Could this be the "magic bullit" for aotuimmune diseases? Read up on this very carefully. If this goes, it will make Dendreon look like childs play. GO BIOTECH!!!!!

It's the bi enhancer that is also a desert topping! (Sorry, for all you older SNL'ers you know what I mean). Interesting product lines that should make the production of biofuels more efficient and lower the overall cost of bringing product to market. Amylase-T pilot trial complete, launce 2008? With big three telling Wash. that they will increase production of alt. Fuel vehicals, seems that stocks in companies from beginning to end of production covers the spread. (Welcome all constructive input as I am still relatively new to this (biofuels)).

Prostate ca vaccine, Knew this was going to bounce. I looked at the data of Phase II trials, not sure why the "experts" were concerned about phase !!!. (exclamation points intentional) Bought between 4.25 and 4.75. Would have bought more Thurs. morn if they had not stopped tradeing. 7/0 vote, commone, no brainer. I feel very confident FDA will approve 5/15. I am backing up the truck on this.